RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.
企業コードRXST
会社名Rxsight Inc
上場日Jul 30, 2021
最高経営責任者「CEO」Dr. Ron M. Kurtz, M.D.
従業員数498
証券種類Ordinary Share
決算期末Jul 30
本社所在地100 Columbia Street
都市ALISO VIEJO
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号92656
電話番号19495217822
ウェブサイトhttps://www.rxsight.com/
企業コードRXST
上場日Jul 30, 2021
最高経営責任者「CEO」Dr. Ron M. Kurtz, M.D.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし